Royal Sense
149.00
-22.50(-13.12%)
Market Cap₹79.76 Cr
PE Ratio14.50
IndustryHealthcare
Company Performance:
1D-13.12%
1M+8.76%
6M-35.50%
1Y-37.92%
5Y+21.39%
View Company Insightsright
More news about Royal Sense
16Dec 25
Royal Sense Limited Secures Major Tender Worth Up to ₹100 Crores from Central Procurement Agency
TTG Innovations Private Limited, set to merge with Royal Sense Limited, has been awarded a significant tender by the Central Procurement Agency under the Directorate General of Health Services. The two-year contract involves supplying comprehensive surgical sutures, potentially increasing sales by up to ₹100 crores. The tender covers various suture types including absorbable, non-absorbable, monofilament, braided, and specialty sutures. This development comes amid ongoing corporate restructuring, with Royal Sense having received a No Objection Certificate from BSE Limited for the proposed merger.
 no imag found
20Nov 25
Royal Sense Limited Receives BSE No-Adverse Observation Letter for Merger with TTG Innovations
Royal Sense Limited (RSL) has received a no-adverse observation letter from BSE Limited for its proposed merger with TTG Innovations Private Limited (TIPL). The letter, issued on November 19, 2025, is valid for six months and allows RSL to file the merger scheme with NCLT, subject to compliance with 15 specific conditions. The merger, approved by RSL's Board on May 26, 2025, involves the absorption of TIPL into RSL under sections 230 to 232 of the Companies Act, 2013. This development marks a significant step forward in the merger process, positioning RSL to proceed with NCLT filing.
 no imag found
12Aug 25
Royal Sense Limited Unveils 'Stergic Pharmacy' Franchise Model, Targets Nationwide Expansion
Royal Sense Limited announced the launch of its new franchise business model, 'Stergic Pharmacy', on August 12, 2025. The initiative aims to establish a network of franchise-owned and company-operated (FOCO) retail stores across India, offering over 500 products. The company has received more than 125 franchise applications and is currently evaluating them. Managing Director Rishabh Arora signed the regulatory filing, emphasizing the importance of this growth strategy in the pharmaceutical retail sector.
 no imag found
Royal Sense
149.00
-22.50
(-13.12%)
1 Year Returns:-37.92%
Industry Peers
Poly Medicure
1,414.20
(-4.96%)
Tarsons Products
206.97
(-2.00%)
Laxmi Dental
189.23
(-2.49%)
Osel Devices
561.80
(+0.04%)
Fabtech Technologies
154.29
(-2.74%)
Vasa Denticity
386.00
(+2.01%)
Prevest Denpro
453.00
(-100.00%)
Aprameya Engineering
212.90
(-5.23%)
Nureca
268.86
(+0.58%)